Overall, the diagnosis and treatment of NF1-associated MPNST emphasize the critical role of complete surgical resection, the potential of combination therapies, and the value of molecular profiling in guiding both treatment and research, particularly in sarcoma subtypes with ambiguous pathology or significant therapeutic heterogeneity. Here, NF1 is linked to malignant peripheral nerve sheath tumor.